Northwestern Is Lead Site for Geron hESC Trial
Northwestern this afternoon confirmed that it is the first site to be ready to accept candidates for hESC clinical trials with Geron, Inc., of Menlo Park, Ca. The Illinois organization is also the lead site for the unprecedented trial.
Northwestern's role surfaced during the weekend in a case involving a severely injured California jockey. See here and h…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.